Scan to Download
One power score. Smarter investment decisions
Transcode Therapeutics Inc
RNAZ11.690USD
+0.460+4.10%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
9.75MMarket Cap
LossP/E TTM
Transcode Therapeutics Inc
11.690
+0.460+4.10%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Operating expenses
-20.46%4.07M
-13.45%2.82M
14.28%4.61M
-59.24%2.15M
17.78%5.11M
-32.35%3.26M
-21.13%4.03M
22.90%5.28M
-7.08%4.34M
38.93%4.82M
82.78%5.11M
84.63%4.30M
1465.47%4.67M
672.14%3.47M
--2.80M
--2.33M
--298.48K
--449.46K
R&D expenses
-16.73%2.57M
26.18%2.22M
8.17%3.64M
-63.28%1.23M
3.90%3.08M
-32.12%1.76M
25.19%3.36M
9.81%3.34M
13.20%2.97M
37.72%2.59M
109.00%2.69M
206.56%3.04M
1137.31%2.62M
613.37%1.88M
--1.29M
--992.95K
--211.75K
--263.76K
Depreciation, depletion, and amortization
-90.59%13.44K
-63.87%51.17K
-12.35%122.86K
-8.11%127.52K
3.81%142.83K
41.37%141.65K
375.08%140.17K
459.56%138.78K
506.18%137.59K
363.86%100.20K
1.78%29.50K
229.16%24.80K
--22.70K
--21.60K
--28.99K
--7.54K
----
----
Other operating expenses
---153.69K
-1185.60%-347.84K
-1680.08%-485.05K
56.44%-11.95K
100.00%0.00
65.93%-27.06K
92.90%-27.25K
95.81%-27.44K
-2171.63%-788.94K
-1036.04%-79.41K
-102.47%-383.77K
-1963.81%-654.95K
39.12%-34.73K
---6.99K
---189.55K
---31.73K
---57.05K
--0.00
Operating profit
20.46%-4.07M
13.45%-2.82M
-14.28%-4.61M
59.24%-2.15M
-17.78%-5.11M
32.35%-3.26M
21.13%-4.03M
-22.90%-5.28M
7.08%-4.34M
-38.93%-4.82M
-82.78%-5.11M
-84.63%-4.30M
-1465.47%-4.67M
-672.14%-3.47M
---2.80M
---2.33M
---298.48K
---449.46K
Net non-operating interest income (expenses)
Non-operating interest income
-16.85%148.00
-13.10%146.00
16.06%159.00
36.64%179.00
-27.64%178.00
-96.48%168.00
-98.58%137.00
-98.54%131.00
-81.52%246.00
979.19%4.77K
1789.41%9.64K
6283.69%9.00K
133000.00%1.33K
3583.33%442.00
--510.00
--141.00
--1.00
--12.00
Non-operating interest expense
----
-98.83%114.00
-96.72%1.83K
-37.55%10.79K
--4.48K
--9.71K
74.76%55.90K
--17.28K
----
----
--31.99K
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--333.00
--41.97K
--52.77K
Gains from sale of securities
34.59%-47.49K
50.88%-27.19K
--228.20K
---157.31K
---72.59K
---55.35K
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
---161.71K
---9.23M
---938.69K
----
----
----
----
----
----
----
----
100.00%0.00
-100.00%0.00
100.00%0.00
--0.00
---1.34K
--3.11M
---3.98M
- Gains from disposal of fixed assets
----
----
--500.00
----
----
----
----
----
----
----
----
----
----
----
---3.08K
----
----
----
Other non-operating income (expenses)
----
----
---596.96K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
17.61%-4.28M
-263.27%-12.09M
-44.73%-5.92M
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
20.38%-4.09M
-23.55%-5.30M
7.06%-4.34M
-38.81%-4.82M
-83.41%-5.13M
-84.13%-4.29M
-268.58%-4.67M
22.64%-3.47M
---2.80M
---2.33M
--2.77M
---4.49M
Income tax
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
Income after tax
17.61%-4.28M
-263.27%-12.09M
-44.73%-5.92M
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
20.38%-4.09M
-23.55%-5.30M
7.06%-4.34M
-38.81%-4.82M
-83.41%-5.13M
-84.13%-4.29M
-268.58%-4.67M
22.64%-3.47M
---2.80M
---2.33M
--2.77M
---4.49M
Net income from continuous operations
17.61%-4.28M
-263.27%-12.09M
-44.73%-5.92M
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
20.38%-4.09M
-23.55%-5.30M
7.06%-4.34M
-38.81%-4.82M
-83.41%-5.13M
-84.13%-4.29M
-268.58%-4.67M
22.64%-3.47M
---2.80M
---2.33M
--2.77M
---4.49M
Net income attributable to controlling interests
17.61%-4.28M
-263.27%-12.09M
-45.48%-5.95M
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
20.38%-4.09M
-23.55%-5.30M
7.06%-4.34M
-38.81%-4.82M
-83.41%-5.13M
-84.13%-4.29M
-268.58%-4.67M
22.64%-3.47M
---2.80M
---2.33M
--2.77M
---4.49M
Preferred share dividend
----
----
--30.60K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to common shareholders
17.61%-4.28M
-263.27%-12.09M
-45.48%-5.95M
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
20.38%-4.09M
-23.55%-5.30M
7.06%-4.34M
-38.81%-4.82M
-83.41%-5.13M
-84.13%-4.29M
-268.58%-4.67M
22.64%-3.47M
---2.80M
---2.33M
--2.77M
---4.49M
Basic earnings per share
99.25%-5.13
88.26%-70.16
95.75%-272.98
99.67%-146.07
99.44%-680.22
99.76%-597.77
97.80%-6.42K
81.68%-44.76K
54.30%-121.61K
-25.09%-247.26K
-82.36%-292.41K
-63.54%-244.34K
-160.23%-266.08K
72.36%-197.66K
---160.35K
---149.41K
--441.79K
---715.15K
Diluted earnings per share
99.25%-5.13
88.26%-70.16
95.75%-272.98
99.67%-146.07
99.44%-680.22
99.76%-597.77
97.80%-6.42K
81.68%-44.76K
54.30%-121.61K
-25.09%-247.26K
-82.36%-292.41K
-63.54%-244.34K
-170.15%-266.08K
72.36%-197.66K
---160.35K
---149.41K
--379.29K
---715.15K
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
